Concepts (125)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Gastrointestinal Motility | 1 | 2019 | 94 | 0.670 |
Why?
|
Adenoma | 5 | 2023 | 736 | 0.510 |
Why?
|
Gastrointestinal Diseases | 1 | 2019 | 602 | 0.490 |
Why?
|
Mediastinal Neoplasms | 1 | 2017 | 426 | 0.430 |
Why?
|
Deglutition Disorders | 1 | 2017 | 475 | 0.420 |
Why?
|
Colonic Polyps | 3 | 2023 | 214 | 0.400 |
Why?
|
Gastroparesis | 2 | 2012 | 81 | 0.370 |
Why?
|
Analgesics, Opioid | 1 | 2019 | 1437 | 0.340 |
Why?
|
Colonoscopy | 4 | 2023 | 527 | 0.330 |
Why?
|
Vagotomy | 1 | 2007 | 26 | 0.300 |
Why?
|
Lymphatic Metastasis | 1 | 2017 | 4940 | 0.290 |
Why?
|
Fundoplication | 1 | 2007 | 70 | 0.280 |
Why?
|
Lymph Nodes | 1 | 2017 | 3038 | 0.270 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2017 | 1906 | 0.260 |
Why?
|
Constipation | 2 | 2019 | 181 | 0.240 |
Why?
|
Peptic Ulcer Hemorrhage | 2 | 2004 | 37 | 0.230 |
Why?
|
Radiotherapy | 1 | 2010 | 1852 | 0.220 |
Why?
|
Neoplasms | 3 | 2023 | 15796 | 0.200 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2017 | 5497 | 0.190 |
Why?
|
Paraneoplastic Syndromes | 1 | 2019 | 82 | 0.170 |
Why?
|
Liver Failure | 1 | 2019 | 142 | 0.160 |
Why?
|
Colorectal Neoplasms | 3 | 2023 | 3676 | 0.160 |
Why?
|
Hepatitis B virus | 1 | 2019 | 210 | 0.150 |
Why?
|
Colonic Neoplasms | 2 | 2016 | 1424 | 0.150 |
Why?
|
Hepatitis B Antibodies | 1 | 2017 | 59 | 0.140 |
Why?
|
Adenine | 1 | 2019 | 651 | 0.140 |
Why?
|
Carcinoembryonic Antigen | 1 | 2016 | 229 | 0.130 |
Why?
|
Argon Plasma Coagulation | 1 | 2014 | 6 | 0.120 |
Why?
|
Virus Activation | 1 | 2017 | 231 | 0.120 |
Why?
|
Fatal Outcome | 1 | 2017 | 833 | 0.120 |
Why?
|
Hemostasis, Endoscopic | 1 | 2014 | 34 | 0.120 |
Why?
|
Piperidines | 1 | 2019 | 1066 | 0.120 |
Why?
|
Antineoplastic Agents, Immunological | 1 | 2023 | 1331 | 0.120 |
Why?
|
Natural Language Processing | 1 | 2015 | 126 | 0.120 |
Why?
|
Endoscopic Mucosal Resection | 1 | 2016 | 113 | 0.120 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2019 | 1051 | 0.110 |
Why?
|
Documentation | 1 | 2015 | 215 | 0.110 |
Why?
|
Hysterectomy | 1 | 2017 | 645 | 0.110 |
Why?
|
Colon | 1 | 2016 | 678 | 0.100 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2014 | 352 | 0.100 |
Why?
|
Transplantation, Autologous | 1 | 2017 | 1980 | 0.100 |
Why?
|
Quality Indicators, Health Care | 1 | 2015 | 376 | 0.100 |
Why?
|
Proctitis | 1 | 2010 | 19 | 0.090 |
Why?
|
Enterocolitis, Neutropenic | 1 | 2010 | 19 | 0.090 |
Why?
|
Transforming Growth Factor beta | 1 | 2016 | 1150 | 0.090 |
Why?
|
Hepatitis | 1 | 2010 | 93 | 0.090 |
Why?
|
Early Detection of Cancer | 2 | 2015 | 1342 | 0.090 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2017 | 1451 | 0.090 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2014 | 622 | 0.080 |
Why?
|
Esophagitis | 1 | 2010 | 204 | 0.080 |
Why?
|
Lymph Node Excision | 1 | 2017 | 2035 | 0.080 |
Why?
|
Vomiting | 1 | 2010 | 361 | 0.080 |
Why?
|
Nausea | 1 | 2010 | 537 | 0.080 |
Why?
|
Vagus Nerve Injuries | 1 | 2007 | 2 | 0.080 |
Why?
|
Combined Modality Therapy | 2 | 2017 | 9020 | 0.070 |
Why?
|
Antineoplastic Agents | 1 | 2010 | 14557 | 0.070 |
Why?
|
Quality Improvement | 1 | 2015 | 929 | 0.070 |
Why?
|
Humans | 16 | 2023 | 271116 | 0.070 |
Why?
|
Diarrhea | 1 | 2010 | 697 | 0.070 |
Why?
|
Multiple Myeloma | 1 | 2017 | 2237 | 0.060 |
Why?
|
Endoscopy, Gastrointestinal | 2 | 2014 | 370 | 0.060 |
Why?
|
Stomach | 1 | 2007 | 393 | 0.060 |
Why?
|
Duodenal Ulcer | 1 | 2004 | 116 | 0.060 |
Why?
|
Cushing Syndrome | 1 | 2004 | 72 | 0.060 |
Why?
|
Computers | 1 | 2023 | 141 | 0.050 |
Why?
|
Adult | 6 | 2023 | 80926 | 0.050 |
Why?
|
Retrospective Studies | 6 | 2023 | 39746 | 0.050 |
Why?
|
Neoplasm Staging | 1 | 2017 | 13883 | 0.050 |
Why?
|
Tertiary Care Centers | 1 | 2023 | 421 | 0.050 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2016 | 9065 | 0.040 |
Why?
|
Graft vs Host Disease | 1 | 2010 | 2736 | 0.040 |
Why?
|
Artificial Intelligence | 1 | 2023 | 440 | 0.040 |
Why?
|
Neuroendocrine Tumors | 1 | 2004 | 649 | 0.040 |
Why?
|
Postoperative Complications | 2 | 2016 | 5854 | 0.040 |
Why?
|
Diagnosis, Differential | 2 | 2012 | 4868 | 0.030 |
Why?
|
Middle Aged | 6 | 2023 | 89687 | 0.030 |
Why?
|
Female | 6 | 2017 | 147682 | 0.030 |
Why?
|
Mutation | 1 | 2016 | 15633 | 0.030 |
Why?
|
Prognosis | 2 | 2007 | 22347 | 0.030 |
Why?
|
Immunoprecipitation | 1 | 2016 | 589 | 0.030 |
Why?
|
Colectomy | 1 | 2016 | 293 | 0.030 |
Why?
|
Vasoconstrictor Agents | 1 | 2014 | 155 | 0.030 |
Why?
|
Immunoenzyme Techniques | 1 | 2016 | 1182 | 0.030 |
Why?
|
Aged | 5 | 2019 | 73028 | 0.030 |
Why?
|
Epinephrine | 1 | 2014 | 259 | 0.030 |
Why?
|
Pylorus | 1 | 2012 | 28 | 0.030 |
Why?
|
Male | 7 | 2019 | 127862 | 0.030 |
Why?
|
Diet Therapy | 1 | 2012 | 53 | 0.030 |
Why?
|
Nutritional Support | 1 | 2012 | 79 | 0.030 |
Why?
|
Gastrointestinal Agents | 1 | 2012 | 120 | 0.020 |
Why?
|
Neuromuscular Agents | 1 | 2012 | 86 | 0.020 |
Why?
|
Acupuncture Therapy | 1 | 2012 | 93 | 0.020 |
Why?
|
Electric Stimulation Therapy | 1 | 2012 | 129 | 0.020 |
Why?
|
Antiemetics | 1 | 2012 | 124 | 0.020 |
Why?
|
Gastric Bypass | 1 | 2012 | 95 | 0.020 |
Why?
|
Fluid Therapy | 1 | 2012 | 182 | 0.020 |
Why?
|
Blood Transfusion | 1 | 2014 | 592 | 0.020 |
Why?
|
Gastrostomy | 1 | 2012 | 189 | 0.020 |
Why?
|
Botulinum Toxins | 1 | 2012 | 136 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2023 | 3116 | 0.020 |
Why?
|
Diabetes Complications | 1 | 2012 | 317 | 0.020 |
Why?
|
Risk Factors | 1 | 2007 | 18047 | 0.020 |
Why?
|
Blotting, Western | 1 | 2016 | 3593 | 0.020 |
Why?
|
Neoplasm, Residual | 1 | 2016 | 1725 | 0.020 |
Why?
|
Gastrectomy | 1 | 2012 | 480 | 0.020 |
Why?
|
Cell Movement | 1 | 2016 | 2511 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2019 | 30849 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2016 | 5679 | 0.020 |
Why?
|
Logistic Models | 1 | 2015 | 3488 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2017 | 6039 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2016 | 2349 | 0.020 |
Why?
|
Pancreatic Neoplasms | 1 | 2004 | 5231 | 0.020 |
Why?
|
Incidence | 1 | 2017 | 5895 | 0.020 |
Why?
|
Recurrence | 1 | 2014 | 4890 | 0.020 |
Why?
|
Survival Rate | 1 | 1999 | 12474 | 0.020 |
Why?
|
Survival Analysis | 1 | 2017 | 9311 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2014 | 6269 | 0.020 |
Why?
|
Disease Progression | 1 | 2016 | 6883 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2016 | 7334 | 0.010 |
Why?
|
Apoptosis | 1 | 2016 | 7756 | 0.010 |
Why?
|
Prospective Studies | 1 | 2015 | 13347 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2017 | 6814 | 0.010 |
Why?
|
Signal Transduction | 1 | 2016 | 12147 | 0.010 |
Why?
|
Biomarkers, Tumor | 1 | 2016 | 10641 | 0.010 |
Why?
|
Young Adult | 1 | 2014 | 22298 | 0.010 |
Why?
|